Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)

China flag China · Delayed Price · Currency is CNY
27.07
+0.18 (0.67%)
Jul 21, 2026, 3:04 PM CST
Market Cap22.85B +53.2%
Revenue (ttm)2.51B +2.1%
Net Income292.97M
EPS0.35
Shares Out 849.93M
PE Ratio76.83
Forward PE84.03
Dividend0.20 (0.71%)
Ex-Dividend DateMay 29, 2026
Volume79,063,831
Open30.51
Previous Close26.89
Day's Range24.61 - 30.51
52-Week Range16.20 - 34.27
Beta0.60
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:002317

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine ... [Read more]

Sector Healthcare
Founded 2001
Employees 1,757
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002317
Full Company Profile

Financial Performance

Financial Statements